Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/114792
| DC Field | Value | Language |
|---|---|---|
| dc.contributor | Department of Applied Biology and Chemical Technology | en_US |
| dc.creator | Wang, M | en_US |
| dc.creator | Zeng, X | en_US |
| dc.creator | Wang, X | en_US |
| dc.creator | Zhang, Z | en_US |
| dc.creator | Guo, S | en_US |
| dc.creator | Deng, Y | en_US |
| dc.creator | Li, X | en_US |
| dc.creator | Yao, L | en_US |
| dc.creator | Li, J | en_US |
| dc.creator | Wong, WL | en_US |
| dc.creator | Bai, Y | en_US |
| dc.creator | Feng, X | en_US |
| dc.date.accessioned | 2025-08-26T03:37:42Z | - |
| dc.date.available | 2025-08-26T03:37:42Z | - |
| dc.identifier.uri | http://hdl.handle.net/10397/114792 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier BV | en_US |
| dc.rights | © 2025 The Authors. Published by Elsevier B.V. on behalf of Shandong University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). | en_US |
| dc.rights | The following publication Wang, M., Zeng, X., Wang, X., Zhang, Z., Guo, S., Deng, Y., Li, X., Yao, L., Li, J., Wong, W.-L., Bai, Y., & Feng, X. (2025). A biodegradable antimicrobial oligomer-containing hydrogel for drug-resistant bacteria-infected skin wound treatment. Pharmaceutical Science Advances, 3, 100091 is available at https://doi.org/10.1016/j.pscia.2025.100091. | en_US |
| dc.subject | Antimicrobial hydrogel | en_US |
| dc.subject | DNA targeting | en_US |
| dc.subject | Membrane disruption | en_US |
| dc.subject | Reactive oxygen species | en_US |
| dc.subject | Wound infection | en_US |
| dc.title | A biodegradable antimicrobial oligomer-containing hydrogel for drug-resistant bacteria-infected skin wound treatment | en_US |
| dc.type | Journal/Magazine Article | en_US |
| dc.identifier.volume | 3 | en_US |
| dc.identifier.doi | 10.1016/j.pscia.2025.100091 | en_US |
| dcterms.abstract | Antibiotic resistance poses a serious global threat, contributing to severe clinical outcomes such as skin and soft tissue infections. Effective treatment of these infections requires both potent antimicrobial activity against resistant pathogens and wound dressings that can conform closely to the wound site. Degradable antimicrobial polymers offer a promising solution to this challenge. Unlike traditional antibiotic-loaded dressings, which often fail against multidrug-resistant (MDR) bacteria, antimicrobial polymers can effectively overcome resistance barriers. Moreover, these polymers can be easily incorporated into wound dressing materials—hydrogels being a particularly advantageous platform due to their biocompatibility and wound-conforming properties. In this study, we developed a modular strategy to integrate a biodegradable cationic antimicrobial oligomer, oligoamidine (OA1), into a thermo-responsive hydrogel. OA1 exerts a triple antibacterial mechanism involving membrane disruption, DNA binding, and ROS generation. The resulting hydrogel system can be conveniently formulated by simple mixing and undergoes a solution-gel transition at body temperature, enabling easy application to infected skin wounds. Importantly, the hydrogel matrix does not impair the bactericidal efficacy of OA1, preserving its full antimicrobial potential. This synergistic system offers an effective and user-friendly approach for treating wounds infected with MDR pathogens. | en_US |
| dcterms.accessRights | open access | en_US |
| dcterms.bibliographicCitation | Pharmaceutical science advances, Dec. 2025, v. 3, 100091 | en_US |
| dcterms.isPartOf | Pharmaceutical science advances | en_US |
| dcterms.issued | 2025-12 | - |
| dc.identifier.eissn | 2773-2169 | en_US |
| dc.identifier.artn | 100091 | en_US |
| dc.description.validate | 202508 bcch | en_US |
| dc.description.oa | Version of Record | en_US |
| dc.identifier.FolderNumber | a3995 | - |
| dc.identifier.SubFormID | 51884 | - |
| dc.description.fundingSource | Others | en_US |
| dc.description.fundingText | The funding support from the National Key Research and Development Program of China (2023YFD1800100 to X.F. and Y. B.), National Natural Science Foundation of China (Grants 22177031 to X.F., 92163127 to Y.B.), Natural Science Foundation of Hunan Province (2024JJ4007 to X.F., 2024JJ2010 to Y.B), Science Fund for Distinguished Young Scholars of Hunan Province (2024RC3078 to X.F., 2022RC1107 to Y.B), Hunan Provincial Key Laboratory of Anti-Resistance Microbial Drugs, the third hospital of Changsha (2023TP1013 to X.F.), Cross fusion research project of Air Force Medical University (2024JC051to X.F.), the Health and Medical Research Fund (HMRF), Hong Kong SAR (22210412 to Wong WL), Hunan Provincial Innovation Foundation For Postgraduate (QL20220075 to J. L.) are gratefully acknowledged. | en_US |
| dc.description.pubStatus | Published | en_US |
| dc.description.oaCategory | CC | en_US |
| Appears in Collections: | Journal/Magazine Article | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 1-s2.0-S2773216925000297-main.pdf | 6.95 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.



